GW Henssler & Associates Ltd. Reduces Its Holdings in The Allstate Co.
GW Henssler & Associates Ltd. has recently decreased its stake in The Allstate Co. (NYSE:ALL) by 1.4% during the fourth quarter, as reported in its latest filing with the SEC. After selling 2,587 shares this quarter, the fund now holds a total of 185,223 shares in the insurance company. This investment represents 2.1% of GW Henssler & Associates Ltd.'s total holdings, ranking as their 8th largest investment. Based on their most recent filings, this investment in Allstate is valued at approximately $35,127,000.
Institutional Investors' Activity
Other institutional investors have made changes to their holdings in Allstate as well. For example, SPC Financial Inc. increased its position by 3.6% during the third quarter, bringing its total to 1,564 shares, valued at $297,000 after acquiring an additional 54 shares. Likewise, Lake Street Advisors Group LLC raised its stake by 1.8%, now owning 3,129 shares worth $596,000. Chicago Partners Investment Group LLC lifted its holdings by 1.3% to reach 4,630 shares valued at $893,000 after adding 59 shares during the same period. Carmichael Hill & Associates Inc. expanded its investment by 15%, now possessing 460 shares worth $87,000. Apella Capital LLC also increased its investment by 1.9% in the fourth quarter, holding 3,231 shares valued at $623,000. Institutional investors own a total of 76.47% of Allstate's stock.
Analyst Ratings
Several analysts have provided updates regarding Allstate. The Goldman Sachs Group raised its price target from $209.00 to $230.00, assigning a "buy" rating in a report released on November 15th. In another shift, Evercore ISI upgraded Allstate from an "in-line" rating to "outperform" on January 8th. Bank of America adjusted their target on Allstate shares from $216.00 to $233.00, maintaining a "buy" rating as of October 18th. Additionally, Morgan Stanley raised their price objective from $220.00 to $228.00 with an "overweight" rating on November 7th. JPMorgan Chase & Co. adjusted its target price from $205.00 to $207.00, also categorizing the stock as "overweight." Currently, the consensus sees the stock as a "Moderate Buy" with an average price target of $218.13 among 14 analysts who rated it as a buy, while one analyst assigned a sell rating.
Allstate Stock Performance
As for the stock performance, shares of Allstate opened at $192.60. Over the past year, they have seen a low of $153.42 and a high of $209.88. The 50-day moving average for the stock is currently sitting at $193.92, while the 200-day moving average is $188.46. Allstate's financial ratios include a quick ratio of 0.40, a current ratio of 0.40, and a debt-to-equity ratio of 0.43. The company holds a market capitalization of $51 billion, with a price-to-earnings ratio of 12.47 and a PEG ratio of 1.45. Its beta value stands at 0.52.
Dividend Announcement
Recently, Allstate announced a quarterly dividend, which shareholders received on January 2nd. Those accurately listed on the record as of November 29th were granted a dividend of $0.92 per share, translating to an annualized dividend of $3.68, yielding a rate of 1.91%. The company's payout ratio is 23.83%, demonstrating a commitment to returning value to shareholders.
About Allstate
The Allstate Corporation, along with its subsidiaries, provides a range of property and casualty insurance products across the United States and Canada. Allstate's operations are segmented into various categories, including Allstate Protection, Protection Services, Allstate Health and Benefits, Run-off Property-Liability, and Corporate and Other segments.
Henssler, Allstate, investments